Natural history of Sudan ebolavirus infection in rhesus and cynomolgus macaques
Open Access
- 14 June 2022
- journal article
- research article
- Published by Taylor & Francis in Emerging Microbes & Infections
- Vol. 11 (1) , 1635-1646
Abstract
Due to its high mortality rate and continued re-emergence, Ebolavirus disease (EVD) continues to pose a serious threat to global health. A group of viruses within the genus Ebolavirus causes this severe hemorrhagic disease in humans: Ebola virus (EBOV; species Zaire ebolavirus), Sudan virus (SUDV; species Sudan ebolavirus), Bundibugyo virus, and Taï Forest virus. EBOV and SUDV are associated with the highest case fatality rates. While the host response to EBOV has been comprehensively examined, limited data exists for SUDV infection. For medical countermeasure testing, well-characterized SUDV nonhuman primate (NHP) models are thus needed. Here, we describe a natural history study in which rhesus (N = 11) and cynomolgus macaques (N = 14) were intramuscularly exposed to a 1000 plaque-forming unit dose of SUDV (Gulu variant). Time-course analyses of various hematological, pathological, serological, coagulation, and transcriptomic findings are reported. SUDV infection was uniformly lethal in cynomolgus macaques (100% mortality), whereas a single rhesus macaque subject (91% mortality) survived to the study endpoint (median time-to-death of ∼8.0 and ∼8.5 days in cynomolgus and rhesus macaques, respectively). Infected macaques exhibited hallmark features of human EVD. The early stage was typified by viremia, granulocytosis, lymphopenia, albuminemia, thrombocytopenia, and decreased expression of HLA-class transcripts. At mid-to-late disease, animals developed fever and petechial rashes, and expressed high levels of pro-inflammatory mediators, pro-thrombotic factors, and markers indicative of liver and kidney injury. End-stage disease was characterized by shock and multi-organ failure. In summary, macaques recapitulate human SUDV disease, supporting these models for use in the development of vaccines and therapeutics.Keywords
Funding Information
- Department of Health, State Government of Victoria
- National Institute of Allergy and Infectious Diseases (U19AI142785)
- NIAID/NIH
This publication has 42 references indexed in Scilit:
- Ebola Hemorrhagic Fever: Novel Biomarker Correlates of Clinical OutcomeThe Journal of Infectious Diseases, 2014
- A Characterization of Aerosolized Sudan Virus Infection in African Green Monkeys, Cynomolgus Macaques, and Rhesus MacaquesViruses, 2012
- Ebola Reston Virus Infection of Pigs: Clinical Significance and Transmission PotentialThe Journal of Infectious Diseases, 2011
- Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte ApoptosisPLOS Neglected Tropical Diseases, 2010
- Blood Chemistry Measurements andd‐Dimer Levels Associated with Fatal and Nonfatal Outcomes in Humans Infected with Sudan Ebola VirusThe Journal of Infectious Diseases, 2007
- Ebola virus: The role of macrophages and dendritic cells in the pathogenesis of Ebola hemorrhagic feverThe International Journal of Biochemistry & Cell Biology, 2005
- Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key EventThe Journal of Infectious Diseases, 2003
- Isolation and partial characterisation of a new strain of Ebola virusThe Lancet, 1995
- Preliminary report: isolation of Ebola virus from monkeys imported to USAThe Lancet, 1990
- VIRAL HÆMORRHAGIC FEVER IN SOUTHERN SUDAN AND NORTHERN ZAIREThe Lancet, 1977